Michael S. Borofsky
NYU Langone Health, University of Minnesota, New York University, Methodist Hospital
Papers
9
Total Citations
517
H-Index
7
About
Michael S. Borofsky is a urologic surgeon and researcher whose work sits at the intersection of surgical innovation, renal preservation, and minimally invasive stone disease. He has made defining contributions to zero-ischemia robotic partial nephrectomy, pioneering the use of near-infrared fluorescence imaging to enable super-selective arterial clamping—a technique that spares healthy kidney tissue during tumor removal. His landmark 2012 paper on this approach has accumulated 146 citations and reshaped nephron-sparing surgery. Borofsky has also advanced benign prostatic hyperplasia (BPH) treatment, comparing outcomes of HoLEP, robot-assisted simple prostatectomy, and the novel water-based Aquablation therapy. His work on Aquablation (29 citations) highlights his focus on reducing invasiveness while preserving efficacy. More recently, he has led efforts to minimize radiation exposure in percutaneous nephrolithotomy (PCNL) through robotic-assisted electromagnetic guidance, showing in both novice and expert studies that this technology improves access success. With over 500 citations across his portfolio, Borofsky is recognized as a leader in robotic urology and endourology, consistently pushing the boundaries of what is possible with image-guided, kidney-sparing surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Live Robotic Surgery: Are Outcomes Compromised?42 citations · 2012
- 6
- 7
- 8
- 9